Vinay Mathew Thomas

535 total citations
52 papers, 312 citations indexed

About

Vinay Mathew Thomas is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Vinay Mathew Thomas has authored 52 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Vinay Mathew Thomas's work include Prostate Cancer Treatment and Research (19 papers), Cancer, Lipids, and Metabolism (8 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Vinay Mathew Thomas is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Cancer, Lipids, and Metabolism (8 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). Vinay Mathew Thomas collaborates with scholars based in United States, India and Ecuador. Vinay Mathew Thomas's co-authors include Neeraj Agarwal, Umang Swami, Nishita Tripathi, Nicolas Sayegh, Ming Y. Lim, Benjamin L. Maughan, Georges Gebrael, Mouhamed Yazan Abou‐Ismail, Kamal Kant Sahu and Aju Mathew and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Vinay Mathew Thomas

42 papers receiving 308 citations

Peers

Countries citing papers authored by Vinay Mathew Thomas

Since Specialization

Citations

This map shows the geographic impact of Vinay Mathew Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinay Mathew Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinay Mathew Thomas more than expected).

Fields of papers citing papers by Vinay Mathew Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinay Mathew Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinay Mathew Thomas. The network helps show where Vinay Mathew Thomas may publish in the future.

Co-authorship network of co-authors of Vinay Mathew Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Vinay Mathew Thomas. A scholar is included among the top collaborators of Vinay Mathew Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinay Mathew Thomas. Vinay Mathew Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world use of bone-modifying agents (BMA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the US. 2025 ·Journal of Clinical Oncology ·Umang Swami, Yeonjung Jo, (unknown), (unknown), Nicolas Sayegh, Georges Gebrael, (unknown), Patrick Campbell, (unknown), (unknown), Vinay Mathew Thomas, Haoran Li, Ryon P. Graf, Soumyajit Roy, Benjamin L. Maughan, Avirup Guha, Irbaz Bin Riaz, Emmanuel S. Antonarakis, Rana R. McKay, (unknown)	0
2	Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial 2024 ·BMC Cancer ·Adriana M. Coletta, (unknown), (unknown), Sarah Taylor, (unknown), Pamela A. Hansen, Vinay Mathew Thomas, Cornelia M. Ulrich, Manish Kohli, Jonathan Chipman, Umang Swami, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal	1
3	Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI 2024 ·JCO Precision Oncology ·Vinay Mathew Thomas, (unknown), Georges Gebrael, Nicolas Sayegh, Nishita Tripathi, Roberto Nussenzveig, Yeonjung Jo, (unknown), (unknown), (unknown), Kamal Kant Sahu, (unknown), Benjamin L. Maughan, Neeraj Agarwal, Umang Swami	1
4	Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor 2024 ·Cancer ·Georges Gebrael, Yeonjung Jo, Vinay Mathew Thomas, (unknown), Nicolas Sayegh, Nishita Tripathi, (unknown), (unknown), (unknown), (unknown), (unknown), Patrick Campbell, (unknown), (unknown), Benjamin L. Maughan, Neeraj Agarwal, Umang Swami	2
5	Natural course of metastatic castration‐resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone‐sensitive setting 2024 ·The Prostate ·Georges Gebrael, (unknown), Nicolas Sayegh, Nishita Tripathi, (unknown), (unknown), (unknown), Taylor Ryan McFarland, (unknown), (unknown), (unknown), (unknown), Yeonjung Jo, (unknown), Vinay Mathew Thomas, Kamal Kant Sahu, Haoran Li, Benjamin L. Maughan, Umang Swami, Neeraj Agarwal	1
6	Gemcitabine with cisplatin and nivolumab: Redefining standard of care for first-line metastatic urothelial carcinoma? 2024 ·Med ·Vinay Mathew Thomas, Petros Grivas, Neeraj Agarwal	1
7	NRAS mutation in melanoma: Association of codon-specific changes on patient outcomes. 2024 ·Journal of Clinical Oncology ·Vinay Mathew Thomas, Tolulope Adeyelu, Farah Abdulla, Ari M. Vanderwalde, Soo J. Park, Jeffery S. Russell	0
8	Precision Medicine in Low- and Middle-Income Countries 2023 ·Vinay Mathew Thomas, Hannah M. Linden, Julie R. Gralow, Katherine Van Loon, (unknown), Marianne Dubard-Gault, Ana Mariá López	1
9	1800P Differential tumor gene-expression profiling of patients (pts) with de-novo metastatic castration-sensitive prostate cancer (dn-mCSPC) versus (vs.) mCSPC relapsing after prior localized therapy (PLT-mCSPC) 2023 ·Annals of Oncology ·Vinay Mathew Thomas, (unknown), Georges Gebrael, Nicolas Sayegh, Nishita Tripathi, Roberto Nussenzveig, (unknown), Kamal Kant Sahu, (unknown), Anupam Srivastava, (unknown), (unknown), John F. Brundage, Benjamin L. Maughan, Umang Swami, Neeraj Agarwal	1
10	Impact of androgen receptor alterations on cell‐free DNA genomic profiling on survival outcomes in metastatic castration‐resistant prostate cancer 2023 ·The Prostate ·Nishita Tripathi, Vinay Mathew Thomas, Nicolas Sayegh, Georges Gebrael, (unknown), Yeonjung Jo, Haoran Li, Kamal Kant Sahu, Roberto Nussenzveig, (unknown), Umang Swami, Neeraj Agarwal, Benjamin L. Maughan	3
11	Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitors 2023 ·Prostate Cancer and Prostatic Diseases ·Georges Gebrael, Nicolas Sayegh, Vinay Mathew Thomas, (unknown), Nishita Tripathi, (unknown), (unknown), Kamal Kant Sahu, (unknown), Taylor Ryan McFarland, Benjamin L. Maughan, Umang Swami, Neeraj Agarwal	12
12	Enhancing Triage Efficiency and Accuracy in Emergency Rooms for Patients with Metastatic Prostate Cancer: A Retrospective Analysis of Artificial Intelligence-Assisted Triage Using ChatGPT 4.0 2023 ·Cancers ·Georges Gebrael, Kamal Kant Sahu, (unknown), Nishita Tripathi, Vinay Mathew Thomas, Nicolas Sayegh, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami, (unknown)	59
13	A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers 2022 ·Heliyon ·(unknown), Kamal Kant Sahu, (unknown), (unknown), Nicolas Sayegh, Nishita Tripathi, Vinay Mathew Thomas, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami	2
14	Detection of BRCA1, and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World Setting 2022 ·Biomedicines ·Taylor Ryan McFarland, Vinay Mathew Thomas, Roberto Nussenzveig, Georges Gebrael, Nicolas Sayegh, Nishita Tripathi, Kamal Kant Sahu, (unknown), Benjamin L. Maughan, Deepika Sirohi, Neeraj Agarwal, Umang Swami	2
15	SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis–Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer 2022 ·Clinical Cancer Research ·Umang Swami, Ryon P. Graf, Roberto Nussenzveig, Virginia Fisher, Hanna Tukachinsky, Alexa B. Schrock, Gerald Li, Jeffrey S. Ross, Nicolas Sayegh, Nishita Tripathi, Vinay Mathew Thomas, Geoffrey R. Oxnard, Emmanuel S. Antonarakis, Neeraj Agarwal	40
16	A Rare Case of Rhino Orbito Cerebral Mucor Mycosis Associated with COVID 19 Infection 2021 ·(unknown), (unknown), (unknown), (unknown), (unknown), Vinay Mathew Thomas, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
17	Lung adenocarcinoma with metastasis to the vitreous – A case report and review of literature 2021 ·SHILAP Revista de lepidopterología ·(unknown), Vinay Mathew Thomas, (unknown), (unknown), (unknown), James J. Vredenburgh	2
18	Bortezomib-induced motor neuropathy: A case report 2020 ·Journal of Oncology Pharmacy Practice ·(unknown), Vinay Mathew Thomas, (unknown)	6
19	1608P Publication rate and characteristics of cancer clinical trials in India 2020 ·Annals of Oncology ·Vinay Mathew Thomas, (unknown), (unknown), Arya Mariam Roy, Aju Mathew	1
20	Nivolumab-induced hepatitis: A rare side effect of an immune check point inhibitor 2019 ·Journal of Oncology Pharmacy Practice ·Vinay Mathew Thomas, (unknown), (unknown), (unknown)	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact